Cargando…
OP4-4 Prevalence, quantification and cut-off level of parvovirus B19 DNA in endomyocardial biopsies of cardiac patients and non-cardiac control subjects
Autores principales: | Goossens, V.J., Dennert, R., Velthuis, S., Schalla, S., van Suylen, R.J., Wolffs, P., Bruggeman, C.A., Waltenberger, J., Crijns, H., Heymans, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128625/ http://dx.doi.org/10.1016/S1386-6532(09)70059-9 |
Ejemplares similares
-
Focal myocardial fibrosis detected with magnetic resonance late Gadolinium enhancement imaging and diffuse interstitial fibrosis determined with histological staining of endomyocardial biopsy specimens in patients with non-ischemic left ventricular systolic dysfunction: two distinct entities?
por: Schalla, Simon, et al.
Publicado: (2009) -
Right ventricular function in dilated cardiomyopathy and ischemic heart disease: assessment with non-invasive imaging
por: Schalla, S., et al.
Publicado: (2015) -
Differences in virus prevalence and load in the hearts of patients with chronic dilated cardiomyopathy with and without immune-mediated inflammatory disease
por: Dennert, R, et al.
Publicado: (2010) -
Cardiac Amyloidosis Diagnosed by Endomyocardial Biopsy
por: Kim, Myung A, et al.
Publicado: (1988) -
Predictors of outcome in patients with parvovirus B19 positive endomyocardial biopsy
por: Greulich, Simon, et al.
Publicado: (2015)